Handelsbanken Fonder
TGTX icon

Handelsbanken Fonder’s TG Therapeutics TGTX Stock Holding History

Handelsbanken Fonder’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Buy
55,000
+7,600
+16% +$311K 0.01% 661
2026
Q1 		$1.57M Hold
47,400
– – 0.01% 832
2025
Q4 		$1.41M Sell
47,400
-100
-0.2% -$3.27K ﹤0.01% 888
2025
Q3 		$1.72M Buy
47,500
+6,900
+17% +$227K 0.01% 787
2025
Q2 		$1.46M Sell
40,600
-5,100
-11% -$190K 0.01% 784
2025
Q1 		$1.8M Hold
45,700
– – 0.01% 692
2024
Q4 		$1.38M Sell
45,700
-4,200
-8% -$121K 0.01% 826
2024
Q3 		$1.17M Buy
49,900
+9,200
+23% +$201K ﹤0.01% 883
2024
Q2 		$724K Buy
40,700
+7,500
+23% +$120K ﹤0.01% 991
2024
Q1 		$505K Hold
33,200
– – ﹤0.01% 1156
2023
Q4 		$567K Buy
33,200
+10,900
+49% +$127K ﹤0.01% 1095
2023
Q3 		$186K Hold
22,300
– – ﹤0.01% 1478
2023
Q2 		$554K Buy
22,300
+10,000
+81% +$258K ﹤0.01% 1014
2023
Q1 		$185K Buy
+12,300
New +$187K ﹤0.01% 1468
2022
Q4 		– Sell
-17,200
Closed -$102K – 1608
2022
Q3 		$102K Hold
17,200
– – ﹤0.01% 1522
2022
Q2 		$73K Sell
17,200
-5,000
-23% -$31.2K ﹤0.01% 1599
2022
Q1 		$211K Hold
22,200
– – ﹤0.01% 1622
2021
Q4 		$422K Hold
22,200
– – ﹤0.01% 1465
2021
Q3 		$739K Hold
22,200
– – ﹤0.01% 1083
2021
Q2 		$861K Buy
22,200
+1,100
+5% +$43.2K ﹤0.01% 1009
2021
Q1 		$1.02M Hold
21,100
– – 0.01% 835
2020
Q4 		$1.1M Hold
21,100
– – 0.01% 782
2020
Q3 		$565K Hold
21,100
– – ﹤0.01% 940
2020
Q2 		$411K Buy
+21,100
New +$340K ﹤0.01% 1056

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Handelsbanken Fonder's TGTX Position: Q2 2026 in Review

Handelsbanken Fonder increased its TG Therapeutics (TGTX) stake by 16% in Q2 2026, buying an estimated $311K and bringing the position to 55,000 shares worth $3.02M. The position accounts for 0.01% of the portfolio, ranked #661.

Handelsbanken Fonder first reported a position in TGTX in Q2 2020 and has held it in 24 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Handelsbanken Fonder held 55,000 shares of TG Therapeutics worth $3.02M as of Q2 2026.
  • Handelsbanken Fonder bought 7,600 TG Therapeutics shares in Q2 2026, an estimated $311K.
  • TG Therapeutics made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #661 holding.
  • Handelsbanken Fonder first reported a position in TG Therapeutics in Q2 2020 and has held it in 24 quarters since.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.